From understanding to rational design of next-generation cancer therapies
This project aims to combine immunotherapy with classical cancer therapies at ultra-low, sublethal doses to maximize efficacy. Informed by single-cell analyses and advanced statistical inference methods, we employ mathematical modeling of intracellular damage dynamics to maximize treatment efficacy.
